{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:55:55Z","timestamp":1793757355447,"version":"4.6.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation for Continuing Education and Research, and the Canadian Association of Oral and Maxillofacial Surgeons"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oral squamous cell carcinoma (OSCC) is often preceded by oral potentially malignant disorders (OPMDs). Despite this known association, the transition from an OPMD to OSCC is complex, unpredictable, and non-linear, making early detection and intervention challenging for clinicians. Histopathological grading, the current standard for risk stratification, is not reliably predictive of malignant transformation (MT), and is subject to significant inter- and intra-observer variability. This scoping review evaluates emerging evidence on the integration of artificial intelligence (AI) and machine learning (ML) with molecular and histopathologic biomarkers to enable individualized risk assessment for MT. Ten retrospective studies incorporating AI\/ML algorithms were analyzed, utilizing biomarkers ranging from gene expression panels, biochemical and protein-based markers like S100A7 to image-derived histomorphometric features. These models demonstrated promising predictive accuracy, with histology-derived features showing the greatest clinical feasibility. However, variability in methodologies, lack of prospective validation, and inconsistent demographic reporting limit the generalizability of the findings. This review highlights the need for multimodal biomarker integration, prospective clinical trials, and validation across broader populations. Ultimately, AI\/ML-enhanced tools hold significant potential to inform personalized surveillance and treatment decisions in OPMD, but their clinical readiness requires further refinement and robust validation.<\/jats:p>","DOI":"10.1186\/s12903-026-08943-x","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:44:53Z","timestamp":1782564293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarker-based machine learning for malignant transformation in oral potentially malignant disorders: a scoping review"],"prefix":"10.1186","volume":"26","author":[{"given":"Kazem","family":"Habibi-Tanha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"M\u00e9n\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Idrissi Janati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"8943_CR1","unstructured":"Cancer CCS. June \/ S canadienne du. Survival statistics for oropharyngeal cancer. Canadian Cancer Society. https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/oropharyngeal\/prognosis-and-survival\/survival-statistics. Accessed 1 2025."},{"key":"8943_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.5732\/cjc.012.10219","volume":"32","author":"B Wang","year":"2013","unstructured":"Wang B, Zhang S, Yue K, Wang X-D. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer. 2013;32:614\u20138. https:\/\/doi.org\/10.5732\/cjc.012.10219.","journal-title":"Chin J Cancer"},{"key":"8943_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309\u201316. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.06.002.","journal-title":"Oral Oncol"},{"key":"8943_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/mco.2021.2351","volume":"15","author":"G Hoene","year":"2021","unstructured":"Hoene G, Gruber RM, Leonhard JJ, Wiechens B, Schminke B, Kauffmann P, et al. Combined quality of life and posttraumatic growth evaluation during follow-up care of patients suffering from oral squamous cell carcinoma. Mol Clin Oncol. 2021;15:189. https:\/\/doi.org\/10.3892\/mco.2021.2351.","journal-title":"Mol Clin Oncol"},{"key":"8943_CR5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ijrobp.2010.07.1988","volume":"81","author":"C-T Liao","year":"2011","unstructured":"Liao C-T, Lee L-Y, Huang S-F, Chen I-H, Kang C-J, Lin C-Y, et al. Outcome analysis of patients with oral cavity cancer and extracapsular spread in neck lymph nodes. Int J Radiat Oncol Biol Phys. 2011;81:930\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.1988.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8943_CR6","volume-title":"WHO Classification of Head and Neck Tumours","author":"Organisation mondiale de la sant\u00e9","year":"2017","unstructured":"Organisation mondiale de la sant\u00e9. Centre international de recherche sur le cancer. editors. WHO Classification of Head and Neck Tumours. 4th ed. Lyon: International agency for research on cancer; 2017.","edition":"4"},{"key":"8943_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.oooo.2023.06.006","volume":"136","author":"C McCord","year":"2023","unstructured":"McCord C, Achita P, Kiss A, Magalhaes MA, Darling M, Bradley G. Progression to malignancy in oral potentially malignant disorders: a retrospective study of 5,036 patients in Ontario, Canada. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;136:466\u201377. https:\/\/doi.org\/10.1016\/j.oooo.2023.06.006.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"8943_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.oooo.2017.12.011","volume":"125","author":"PM Speight","year":"2018","unstructured":"Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:612\u201327. https:\/\/doi.org\/10.1016\/j.oooo.2017.12.011.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"8943_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/cgt.2016.43","volume":"23","author":"KK Dey","year":"2016","unstructured":"Dey KK, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38\/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382\u201391. https:\/\/doi.org\/10.1038\/cgt.2016.43.","journal-title":"Cancer Gene Ther"},{"key":"8943_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/154411130301400105","volume":"14","author":"J Reibel","year":"2003","unstructured":"Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med Off Publ Am Assoc Oral Biol. 2003;14:47\u201362. https:\/\/doi.org\/10.1177\/154411130301400105.","journal-title":"Crit Rev Oral Biol Med Off Publ Am Assoc Oral Biol"},{"key":"8943_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06036-1","author":"F Yan","year":"2020","unstructured":"Yan F, Reddy PD, Nguyen SA, Chi AC, Neville BW, Day TA. Grading systems of oral cavity pre-malignancy: a systematic review and meta-analysis. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol-Head Neck Surg. 2020;277:2967\u201376. https:\/\/doi.org\/10.1007\/s00405-020-06036-1"},{"key":"8943_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/jop.12592","volume":"46","author":"G Prasad","year":"2017","unstructured":"Prasad G, Seers C, Reynolds E, McCullough MJ. A panel of microRNAs can be used to determine oral squamous cell carcinoma. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2017;46:940\u20138. https:\/\/doi.org\/10.1111\/jop.12592.","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"8943_CR13","doi-asserted-by":"publisher","first-page":"e11148","DOI":"10.1371\/journal.pone.0011148","volume":"5","author":"EP de Jong","year":"2010","unstructured":"de Jong EP, Xie H, Onsongo G, Stone MD, Chen X-B, Kooren JA, et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS ONE. 2010;5:e11148. https:\/\/doi.org\/10.1371\/journal.pone.0011148.","journal-title":"PLoS ONE"},{"key":"8943_CR14","first-page":"355","volume":"17","author":"T Fillies","year":"2007","unstructured":"Fillies T, Woltering M, Brandt B, Van Diest J-P, Werkmeister R, Joos U, et al. Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas. Oncol Rep. 2007;17:355\u20139.","journal-title":"Oncol Rep"},{"key":"8943_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1600-0714.2007.00546.x","volume":"36","author":"J-C de Vicente","year":"2007","unstructured":"de Vicente J-C, Lequerica-Fern\u00e1ndez P, Santamar\u00eda J, Fresno M-F. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2007;36:415\u201324. https:\/\/doi.org\/10.1111\/j.1600-0714.2007.00546.x.","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"8943_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H, et al. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J Transl Med. 2025;23:548. https:\/\/doi.org\/10.1186\/s12967-025-06526-y.","journal-title":"J Transl Med"},{"key":"8943_CR17","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/odi.13704","volume":"27","author":"S Warnakulasuriya","year":"2021","unstructured":"Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, Gonz\u00e1lez-Moles M\u00c1, Kerr AR, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862\u201380. https:\/\/doi.org\/10.1111\/odi.13704.","journal-title":"Oral Dis"},{"key":"8943_CR18","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1158\/1078-0432.CCR-15-1761","volume":"22","author":"FO Gleber-Netto","year":"2016","unstructured":"Gleber-Netto FO, Yakob M, Li F, Feng Z, Dai J, Kao H-K, et al. Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population. Clin Cancer Res Off J Am Assoc Cancer Res. 2016;22:3340\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1761.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"8943_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hed.26006","volume":"42","author":"O Iocca","year":"2020","unstructured":"Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42:539\u201355. https:\/\/doi.org\/10.1002\/hed.26006.","journal-title":"Head Neck"},{"key":"8943_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.archoralbio.2007.05.005","volume":"52","author":"L Zhong","year":"2007","unstructured":"Zhong L, Zhang C, Zheng J, Li J, Chen W, Zhang Z. Increased Cyfra 21\u2009\u2013\u20091 concentration in saliva from primary oral squamous cell carcinoma patients. Arch Oral Biol. 2007;52:1079\u201387. https:\/\/doi.org\/10.1016\/j.archoralbio.2007.05.005.","journal-title":"Arch Oral Biol"},{"key":"8943_CR21","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41416-023-02438-0","volume":"129","author":"H Mahmood","year":"2023","unstructured":"Mahmood H, Shephard A, Hankinson P, Bradburn M, Araujo ALD, Santos-Silva AR, et al. Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia. Br J Cancer. 2023;129:1599\u2013607. https:\/\/doi.org\/10.1038\/s41416-023-02438-0.","journal-title":"Br J Cancer"},{"key":"8943_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41698-024-00624-8","volume":"8","author":"AJ Shephard","year":"2024","unstructured":"Shephard AJ, Bashir RMS, Mahmood H, Jahanifar M, Minhas F, Raza SEA, et al. A fully automated and explainable algorithm for predicting malignant transformation in oral epithelial dysplasia. Npj Precis Oncol. 2024;8:137. https:\/\/doi.org\/10.1038\/s41698-024-00624-8.","journal-title":"Npj Precis Oncol"},{"key":"8943_CR23","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.31557\/APJCP.2022.23.5.1483","volume":"23","author":"AK Shaw","year":"2022","unstructured":"Shaw AK, Garcha V, Shetty V, Vinay V, Bhor K, Ambildhok K, et al. Diagnostic accuracy of salivary biomarkers in detecting early oral squamous cell carcinoma: a systematic review and meta-analysis. Asian Pac J Cancer Prev APJCP. 2022;23:1483\u201395. https:\/\/doi.org\/10.31557\/APJCP.2022.23.5.1483.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"8943_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jdsr.2023.10.003","volume":"60","author":"S Khijmatgar","year":"2024","unstructured":"Khijmatgar S, Yong J, R\u00fcbsamen N, Lorusso F, Rai P, Cenzato N, et al. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head\/neck squamous cell carcinoma (HNSCC): a systematic review and network meta-analysis. Jpn Dent Sci Rev. 2024;60:32\u20139. https:\/\/doi.org\/10.1016\/j.jdsr.2023.10.003.","journal-title":"Jpn Dent Sci Rev"},{"key":"8943_CR25","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18:2119\u201326. https:\/\/doi.org\/10.11124\/JBIES-20-00167.","journal-title":"JBI Evid Synth"},{"key":"8943_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"8943_CR27","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org."},{"key":"8943_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"8943_CR29","volume-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2016","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring (MD): Food and Drug Administration (US); 2016."},{"key":"8943_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.oooo.2016.11.004","volume":"123","author":"JTK Hwang","year":"2017","unstructured":"Hwang JTK, Gu YR, Shen M, Ralhan R, Walfish PG, Pritzker KPH, et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123:374\u201381. https:\/\/doi.org\/10.1016\/j.oooo.2016.11.004.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"8943_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cjp2.182","volume":"7","author":"A Ali","year":"2021","unstructured":"Ali A, Soares AB, Eymael D, Magalhaes M. Expression of invadopodia markers can identify oral lesions with a high risk of malignant transformation. J Pathol Clin Res. 2021;7:61\u201374. https:\/\/doi.org\/10.1002\/cjp2.182.","journal-title":"J Pathol Clin Res"},{"key":"8943_CR32","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.3390\/cancers14235808","volume":"14","author":"F Jing","year":"2022","unstructured":"Jing F, Zhang J, Cai X, Zhou X, Bai J, Zhang H, et al. Screening for biomarkers for progression from oral leukoplakia to oral squamous cell carcinoma and evaluation of diagnostic efficacy by multiple machine learning algorithms. Cancers. 2022;14:5808. https:\/\/doi.org\/10.3390\/cancers14235808.","journal-title":"Cancers"},{"key":"8943_CR33","unstructured":"Shams WK, Htike ZZ. Oral Cancer Prediction Using Gene Expression Profiling Mach Learn. 2017;12."},{"key":"8943_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/PAI.0000000000001132","volume":"31","author":"MR Darling","year":"2023","unstructured":"Darling MR, Hwang JTK, Dickson BJ, Cutz J-C, Salama S, McCord C, et al. Assessing oral epithelial dysplasia risk for transformation to cancer: comparison between histologic grading systems versus S100A7 immunohistochemical signature-based grading. Appl Immunohistochem Mol Morphol AIMM. 2023;31:399\u2013405. https:\/\/doi.org\/10.1097\/PAI.0000000000001132.","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"key":"8943_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.6094","volume":"260","author":"RMS Bashir","year":"2023","unstructured":"Bashir RMS, Shephard AJ, Mahmood H, Azarmehr N, Raza SEA, Khurram SA, et al. A digital score of peri-epithelial lymphocytic activity predicts malignant transformation in oral epithelial dysplasia. J Pathol. 2023;260:431\u201342. https:\/\/doi.org\/10.1002\/path.6094.","journal-title":"J Pathol"},{"key":"8943_CR36","doi-asserted-by":"publisher","first-page":"e0266043","DOI":"10.1371\/journal.pone.0266043","volume":"17","author":"BG Ellis","year":"2022","unstructured":"Ellis BG, Whitley CA, Triantafyllou A, Gunning PJ, Smith CI, Barrett SD, et al. Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra. PLoS ONE. 2022;17:e0266043. https:\/\/doi.org\/10.1371\/journal.pone.0266043.","journal-title":"PLoS ONE"},{"key":"8943_CR37","doi-asserted-by":"publisher","first-page":"46057","DOI":"10.18632\/oncotarget.17550","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Li Y, Fu Y, Liu T, Liu X, Zhang X, et al. Quantitative prediction of oral cancer risk in patients with oral leukoplakia. Oncotarget. 2017;8:46057\u201364. https:\/\/doi.org\/10.18632\/oncotarget.17550.","journal-title":"Oncotarget"},{"key":"8943_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.beth.2020.05.002","volume":"51","author":"T Jiang","year":"2020","unstructured":"Jiang T, Gradus JL, Rosellini AJ. Supervised machine learning: a brief primer. Behav Ther. 2020;51:675\u201387. https:\/\/doi.org\/10.1016\/j.beth.2020.05.002.","journal-title":"Behav Ther"},{"key":"8943_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/nsr\/nwx106","volume":"5","author":"Z-H Zhou","year":"2018","unstructured":"Zhou Z-H. A brief introduction to weakly supervised learning. Natl Sci Rev. 2018;5:44\u201353. https:\/\/doi.org\/10.1093\/nsr\/nwx106.","journal-title":"Natl Sci Rev"},{"key":"8943_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/649498","volume":"2012","author":"LM Brown","year":"2012","unstructured":"Brown LM, Check DP, Devesa SS. Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. J Oncol. 2012;2012:1\u201310. https:\/\/doi.org\/10.1155\/2012\/649498.","journal-title":"J Oncol"},{"key":"8943_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jop.12726","volume":"47","author":"FW Mello","year":"2018","unstructured":"Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47:633\u201340. https:\/\/doi.org\/10.1111\/jop.12726.","journal-title":"J Oral Pathol Med"},{"key":"8943_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jobcr.2015.11.002","volume":"6","author":"MP Singh","year":"2016","unstructured":"Singh MP, Kumar V, Agarwal A, Kumar R, Bhatt MLB, Misra S. Clinico-epidemiological study of oral squamous cell carcinoma: a tertiary care centre study in North India. J Oral Biol Craniofac Res. 2016;6:32\u20135. https:\/\/doi.org\/10.1016\/j.jobcr.2015.11.002.","journal-title":"J Oral Biol Craniofac Res"},{"key":"8943_CR43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/1471-2407-9-260","volume":"9","author":"P-S Ho","year":"2009","unstructured":"Ho P-S, Chen P-L, Warnakulasuriya S, Shieh T-Y, Chen Y-K, Huang I-Y. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009;9:260. https:\/\/doi.org\/10.1186\/1471-2407-9-260.","journal-title":"BMC Cancer"},{"key":"8943_CR44","doi-asserted-by":"publisher","first-page":"111387","DOI":"10.1016\/j.jclinepi.2024.111387","volume":"172","author":"HM la Roi-Teeuw","year":"2024","unstructured":"la Roi-Teeuw HM, van Royen FS, de Hond A, Zahra A, de Vries S, Bartels R, et al. Don\u2019t be misled: 3 misconceptions about external validation of clinical prediction models. J Clin Epidemiol. 2024;172:111387. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111387.","journal-title":"J Clin Epidemiol"},{"key":"8943_CR45","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KGM Moons","year":"2015","unstructured":"Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1\u201373. https:\/\/doi.org\/10.7326\/M14-0698.","journal-title":"Ann Intern Med"},{"key":"8943_CR46","doi-asserted-by":"publisher","first-page":"e240300","DOI":"10.1148\/ryai.240300","volume":"6","author":"AS Tejani","year":"2024","unstructured":"Tejani AS, Klontzas ME, Gatti AA, Mongan JT, Moy L, Park SH, et al. Checklist for Artificial Intelligence in Medical imaging (CLAIM): 2024 update. Radiol Artif Intell. 2024;6:e240300. https:\/\/doi.org\/10.1148\/ryai.240300.","journal-title":"Radiol Artif Intell"},{"key":"8943_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96\u2013109. https:\/\/doi.org\/10.1038\/nrc3893.","journal-title":"Nat Rev Cancer"},{"key":"8943_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.oraloncology.2008.11.012","volume":"45","author":"MR Kesting","year":"2009","unstructured":"Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff K-D, et al. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol. 2009;45:731\u20136. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.11.012.","journal-title":"Oral Oncol"},{"key":"8943_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1158\/0008-5472.CAN-11-0669","volume":"72","author":"MW Nasser","year":"2012","unstructured":"Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, et al. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res. 2012;72:604\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0669.","journal-title":"Cancer Res"},{"key":"8943_CR50","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1038\/sj.onc.1211015","volume":"27","author":"G Zhou","year":"2008","unstructured":"Zhou G, Xie T-X, Zhao M, Jasser SA, Younes MN, Sano D, et al. Reciprocal negative regulation between S100A7\/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene. 2008;27:3527\u201338. https:\/\/doi.org\/10.1038\/sj.onc.1211015.","journal-title":"Oncogene"},{"key":"8943_CR51","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/2326-6066.CIR-15-0017","volume":"3","author":"JE Glogauer","year":"2015","unstructured":"Glogauer JE, Sun CX, Bradley G, Magalhaes MAO. Neutrophils increase oral squamous cell carcinoma invasion through an invadopodia-dependent pathway. Cancer Immunol Res. 2015;3:1218\u201326. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0017.","journal-title":"Cancer Immunol Res"},{"key":"8943_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5277440","volume":"2022","author":"K Kato","year":"2022","unstructured":"Kato K, Miyazawa H, Kawashiri S, Lambert DW. Tumour: fibroblast interactions promote invadopodia-mediated migration and invasion in oral squamous cell carcinoma. J Oncol. 2022;2022:1\u201311. https:\/\/doi.org\/10.1155\/2022\/5277440.","journal-title":"J Oncol"},{"key":"8943_CR53","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3390\/biom11121879","volume":"11","author":"N Kaunein","year":"2021","unstructured":"Kaunein N, Ramani RS, Koo K, Moore C, Celentano A, McCullough M, et al. A systematic review of microRNA signatures associated with the progression of leukoplakia with and without epithelial dysplasia. Biomolecules. 2021;11:1879. https:\/\/doi.org\/10.3390\/biom11121879.","journal-title":"Biomolecules"},{"key":"8943_CR54","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12672-025-01923-7","volume":"16","author":"S Kojima","year":"2025","unstructured":"Kojima S, Kuribayashi N, Goda H, Nakashiro K-I, Uchida D. Oral cancer driver gene mutations in oral potentially malignant disorders: clinical significance and diagnostic implications. Discov Oncol. 2025;16:174. https:\/\/doi.org\/10.1007\/s12672-025-01923-7.","journal-title":"Discov Oncol"},{"key":"8943_CR55","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"The Cancer Genome Atlas Network","year":"2015","unstructured":"The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576\u201382. https:\/\/doi.org\/10.1038\/nature14129.","journal-title":"Nature"},{"key":"8943_CR56","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1080\/05704928.2021.1946076","volume":"56","author":"M Paraskevaidi","year":"2021","unstructured":"Paraskevaidi M, Matthew BJ, Holly BJ, Hugh BJ, Thulya CPV, Loren C, et al. Clinical applications of infrared and Raman spectroscopy in the fields of cancer and infectious diseases. Appl Spectrosc Rev. 2021;56:804\u201368. https:\/\/doi.org\/10.1080\/05704928.2021.1946076.","journal-title":"Appl Spectrosc Rev"},{"key":"8943_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.joms.2005.11.028","volume":"64","author":"A Chandu","year":"2006","unstructured":"Chandu A, Smith ACH, Rogers SN. Health-Related Quality of Life in Oral Cancer: A Review. J Oral Maxillofac Surg. 2006;64:495\u2013502. https:\/\/doi.org\/10.1016\/j.joms.2005.11.028.","journal-title":"J Oral Maxillofac Surg"},{"key":"8943_CR58","unstructured":"Canada H. Guidance Document: Software as a Medical Device (SaMD): Definition and Classification. 2021. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/application-information\/guidance-documents\/software-medical-device-guidance-document.html. Accessed 6 Apr 2026."},{"key":"8943_CR59","unstructured":"U.S. Food and Drug Administration. Proposed regulatory framework for modifications to artificial intelligence\/machine learning (AI\/ML)-based software as a medical device (SaMD): discussion paper and request for feedback. Silver Spring (MD): FDA; 2019."},{"key":"8943_CR60","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/cancers12082273","volume":"12","author":"Y-T Chang","year":"2020","unstructured":"Chang Y-T, Chu LJ, Liu Y-C, Chen C-J, Wu S-F, Chen C-H, et al. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer. Cancers. 2020;12:2273. https:\/\/doi.org\/10.3390\/cancers12082273.","journal-title":"Cancers"},{"key":"8943_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41432-022-0249-8","volume":"23","author":"F Elmahgoub","year":"2022","unstructured":"Elmahgoub F. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors? Evid Based Dent. 2022;23:30\u20131. https:\/\/doi.org\/10.1038\/s41432-022-0249-8.","journal-title":"Evid Based Dent"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08943-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:22:50Z","timestamp":1786101770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08943-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8943"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08943-x","relation":{"references":[{"id-type":"doi","id":"10.1007\/s00405-020-06036-1","asserted-by":"subject"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1381"}}